Nordic Institute of Health Economics A/S

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 0.0% 8.9% 3.6%  
Credit score (0-100)  0 0 0 27 51  
Credit rating  N/A N/A N/A BB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 0.0 1,899 2,805  
EBITDA  0.0 0.0 0.0 -534 357  
EBIT  0.0 0.0 0.0 -576 305  
Pre-tax profit (PTP)  0.0 0.0 0.0 -617.4 238.5  
Net earnings  0.0 0.0 0.0 -486.4 185.8  
Pre-tax profit without non-rec. items  0.0 0.0 0.0 -617 238  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 163 110  
Shareholders equity total  0.0 0.0 0.0 -86.4 99.4  
Interest-bearing liabilities  0.0 0.0 0.0 1,150 919  
Balance sheet total (assets)  0.0 0.0 0.0 1,737 2,113  

Net Debt  0.0 0.0 0.0 952 220  
 
See the entire balance sheet

Volume 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 0.0 1,899 2,805  
Gross profit growth  0.0% 0.0% 0.0% 0.0% 47.7%  
Employees  0 0 0 3 4  
Employee growth %  0.0% 0.0% 0.0% 0.0% 33.3%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 0 1,737 2,113  
Balance sheet change%  0.0% 0.0% 0.0% 0.0% 21.7%  
Added value  0.0 0.0 0.0 -576.0 357.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 121 -106  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 0.0 -1.0 1.0  

Profitability 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 0.0% -30.3% 10.9%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 0.0% -31.6% 15.6%  
ROI %  0.0% 0.0% 0.0% -48.6% 27.6%  
ROE %  0.0% 0.0% 0.0% -28.0% 20.2%  

Solidity 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Equity ratio %  0.0% 0.0% 0.0% -4.7% 6.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 0.0% -178.3% 61.5%  
Gearing %  0.0% 0.0% 0.0% -1,330.7% 924.4%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 7.2% 6.6%  

Liquidity 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Quick Ratio  0.0 0.0 0.0 0.8 1.3  
Current Ratio  0.0 0.0 0.0 0.8 1.0  
Cash and cash equivalent  0.0 0.0 0.0 198.0 698.9  

Capital use efficiency 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 0.0 -270.7 -49.7  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 -192 89  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 -178 89  
EBIT / employee  0 0 0 -192 76  
Net earnings / employee  0 0 0 -162 46